Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipelineDren Bio deep B-cell ...
Interesting Engineering on MSN8h
Game-changer in cancer treatment: Antibody therapy to replace invasive surgeriesOxford BioTherapeutics (OBT), a clinical-stage oncology firm, has announced a long-term partnership with Roche ...
Global Bispecific Antibodies market size to surpass US$ 50 Billion By 2030 Says Kuick Research Delhi, March 17, 2025 (GLOBE ...
Chugai introduces Lunsumio for intravenous infusion, a bispecific antibody to treat relapsed or refractory follicular lymphoma in Japan: Tokyo Thursday, March 20, 2025, 11:00 Hrs ...
Merus (NASDAQ:MRUS – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at Guggenheim in a report issued on Tuesday,Benzinga reports. They presently have a $109.00 target price ...
Continues focus on development of bispecific anti-cancer agents with differentiated mechanisms of action SEATTLE, WASHINGTON / ACCESS Newswire / March 18, 2025 / Aptevo Therapeutics (NASDAQ:APVO), a ...
China’s Harbour BioMed has launched a new biotech to develop bispecific antibodies focused on the holy grail of next-gen ...
Evinova makes it possible for us to monitor people using the drug every day, from the comfort of their home. Using Evinova’s RPM solution in the study will help us, as providers, to identify and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback